Optimer's Deal With Cubist Gives Dificid Experienced Hospital Sales Force Support
This article was originally published in The Pink Sheet Daily
Executive Summary
Optimer expects the co-promotion to accelerate formulary adoption and uptake of the antibiotic at the 1,100 hospitals where 70% of hospital-related Clostridium dificile infections occur.